AGREEMENT BY AND BETWEEN SYBLEU INC. AND ONCOLOGY PHARMA INC.Agreement by And • February 25th, 2021 • SYBLEU Inc • Pharmaceutical preparations • California
Contract Type FiledFebruary 25th, 2021 Company Industry JurisdictionTHIS LICENSE AGREEMENT, including the exhibits referred to herein and attached hereto (the “Agreement”), effective as of 2-24, 2021 (the “Effective Date”), is made and entered into by and between SYBLEU INC., a Wyoming corporation (“Licensor”) and Oncology Pharma, Inc., a Nevada corporation (“Licensee”). Licensor and Licensee may be referred to in this Agreement each as a “Party” or collectively as the “Parties.”
AGREEMENT BY AND BETWEEN SYBLEU INC. INC. AND DR. JASON E. GARBERAgreement by And • November 3rd, 2020 • SYBLEU Inc • Pharmaceutical preparations • California
Contract Type FiledNovember 3rd, 2020 Company Industry JurisdictionAgreement made on July 7,2020 (“Execution Date”) by and between Dr. Jason E. Garber (“Scientific Advisory Board Member” also referred to as “SAB Member”), a natural person whose address is at 3012 South Durango, Las Vegas NV and SYBLEU INC. Inc. (“Company”), a Wyoming corporation whose principal office address is 4700 Spring Street, Suite 304, La Mesa CA 91942. SAB Member and Company may be referred to individually as “Party” and collectively as “Parties”.
AGREEMENT BY AND BETWEEN SYBLEU INC. INC. AND JOANNE VAINIAgreement by And • January 17th, 2023 • SYBLEU Inc • Pharmaceutical preparations
Contract Type FiledJanuary 17th, 2023 Company IndustryAgreement made on January 8, 2023 by and between Joanne Vaini (“Consultant”) and SYBLEU INC. Inc. (“Company”), a Wyoming corporation. Consultant and Company may be referred to individually as “Party” and collectively as “Parties”.
EMPLOYMENT AGREEMENT BETWEEN SYBLEU INC AND Harry M. Lander, Ph.D., M.B.A.Employment Agreement • December 12th, 2022 • SYBLEU Inc • Pharmaceutical preparations • California
Contract Type FiledDecember 12th, 2022 Company Industry JurisdictionTHIS EMPLOYMENT AGREEMENT (the "Agreement") dated as of December 9 ,2022 is entered into between SYBLEU INC, a Wyoming corporation, (the "Company") and Harry M. Lander ("Employee").
STOCK AND NOTE PURCHASE AGREEMENT betweenTermination Agreement and Release • April 18th, 2024 • SYBLEU Inc • Pharmaceutical preparations • Utah
Contract Type FiledApril 18th, 2024 Company Industry JurisdictionThis Stock and Note Purchase Agreement (this “Agreement”), dated as of April 12, 2024, is entered into between SYBLEU Inc., a Wyoming corporation (“Company”), Worldwide Holdings Investment Group, L.L.C., a Utah limited liability company (“Purchaser”), Zander Therapeutics, Inc. (“Zander Therapeutics, Inc.”), Zander Biologics, Inc. (“Zander Biologics”), Bostonia Partners, Inc. (“Bostonia” and, together with Zander Therapeutics, Inc. and Zander Biologics, the “Noteholders”), Harry Lander (“Lander”) and Joseph G. Vaini (“Vaini” and, together with Lander, the “Sellers”). Capitalized terms used in this Agreement have the meanings given to such terms herein.
ContractStock Purchase Agreement • November 9th, 2020 • SYBLEU Inc • Pharmaceutical preparations • California
Contract Type FiledNovember 9th, 2020 Company Industry JurisdictionTHIS STOCK PURCHASE AGREEMENT (the “Agreement”) is entered into by and among SYBLEU INC., a Wyoming corporation (the “Company”) whose address is 4700 Spring Street, St 304, La Mesa, California 91942 and Stephen and Fredna Hake TTES FBO The Stephen and Fredna Hake Trust DTD August 6, 2014 (“Purchaser”), a Nevada Trust whose address is 290 Saddle Run Street, Henderson Nevada 89012.
AGREEMENT BY AND BETWEEN REGEN SYBLEU INC. ( SYBE) AND ZANDER BIOLOGICS, INC.(ZAND). (“Agreement”) SYBE and ZAND may be referred to in this Agreement each as a “Party” or collectively as the “Parties.” This Agreement is dated June 30, 2023Agreement by And • July 7th, 2023 • SYBLEU Inc • Pharmaceutical preparations
Contract Type FiledJuly 7th, 2023 Company IndustryWHEREAS ZAND holds all right, title and interest in and to including, but not limited to, the copyrights, trade secrets, trademarks and associated good will and patent rights to the intellectual property described in Exhibit A. (“IP Rights”)
CONSULTING AGREEMENT BY AND BETWEEN ZEN DATA LLC AND SYBLEU INC.Consulting Agreement by And • August 17th, 2020 • SYBLEU Inc • California
Contract Type FiledAugust 17th, 2020 Company JurisdictionAgreement made on made on June 23, 2020 by and between Zen Data LLC (“Consultant”) , a _______ whose address is at is 109 East 17th Street Suite 460 Cheyenne WY 82001 and Sybleu Inc. (“Company”) , a Wyoming corporation. Consultant and Company may be referred to individually as “Party” and collectively as “Parties”.
CONSULTING AGREEMENT BY AND BETWEEN TGF CONSULTING LLC AND SYBLEU INC.Consulting Agreement by And • August 17th, 2020 • SYBLEU Inc • California
Contract Type FiledAugust 17th, 2020 Company JurisdictionAgreement made on made on July 2, 2020 by and between TGF Consulting LLC (“Consultant”) , whose address is at 109 East 17th Street Suite 460 Cheyenne WY 82001 and Sybleu Inc. (“Company”) , a Wyoming corporation whose address is 4700 Spring Street St.304 La Mesa CA 91942 . Consultant and Company may be referred to individually as “Party” and collectively as “Parties”.
AGREEMENT BY AND BETWEEN SYBLEU INC AND TIMOTHY G FOATAgreement by And • March 27th, 2023 • SYBLEU Inc • Pharmaceutical preparations • New York
Contract Type FiledMarch 27th, 2023 Company Industry JurisdictionAgreement by and between Timothy G. Foat (“Consultant”) , a natural person and SYBLEU INC (“Company”) , a Wyoming corporation whose address is 1034 Throggs Neck Expressway Bronx NY 10465 dated March 13, 2023.
AGREEMENT BY AND BETWEEN SYBLEU INC. AND DYO BIOTECHNOLOGIES, PTY, LTDAgreement by And • June 26th, 2023 • SYBLEU Inc • Pharmaceutical preparations
Contract Type FiledJune 26th, 2023 Company IndustryTHIS LICENSE AGREEMENT, including the exhibits referred to herein and attached hereto (the “Agreement”), effective as of June 26, 2023 (the “Effective Date”), is made and entered into by and between SYBLEU INC., a Wyoming corporation (“Company”) and DYO Biotechnologies, Pty, Ltd (“DYO”) a Singapore company. Company and DYO may be referred to in this Agreement each as a “Party” or collectively as the “Parties.”